In July 2022, the FDA earned approval for the new Prodisc C Nova, according to an Oct. 31 news release.
This is Centinel’s third new cervical TDR product released since late 2022. The Prodisc C Vivo and Prodisc C SK products were both introduced on a limited basis in late 2022 and have been used in over 8,000 procedures since.
Alex Sielatycki, MD, a surgeon at Steamboat Orthopedic & Spine Institute in Steamboat Springs, Colo., performed the first Prodisc C Nova procedure.
Prodisc C Nova was co-developed by spine surgeon Rudolf Bertagnoli, MD, in Straubing, Germany, and first implanted in Europe in 2009.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
